Author

Kalarickal Vijayan Dileep

Observed names: Dileep K V, Dileep K. V., Dileep K. Vijayan, Dileep K.V, Dileep Vijayan, K V Dileep, K. V. Dileep, K.V. Dileep, KV Dileep, Kalarickal V Dileep, Kalarickal V. Dileep, Kalarikkal V. Dileep, V., Dileep K.

Observed institutions: Jagiellonian University, Amrita Institute of Medical Sciences and Research Centre, Cedars-Sinai Medical Center, Texas Biomedical Research Institute, The University of Texas at San Antonio Health Science Center, Jubilee Mission Medical College and Research Institute, RIKEN, RIKEN Center for Biosystems Dynamics Research, Evestra (United States), Mays Cancer Center at UT Health San Antonio, College of Engineering Trivandrum, Indian Institute of Science Education and Research Thiruvananthapuram, Kannur University, Amrita Vishwa Vidyapeetham, The University of Texas Southwestern Medical Center

ORCID: 0000-0002-7456-4226

Observed ORCID: 0000-0002-7456-4226

OpenAlex ID: A5086825763

Anti‐Inflammatory Property of n ‐Hexadecanoic Acid: Structural Evidence and Kinetic Assessment

2012 · Vasudevan Aparna, Kalarickal V. Dileep, et al. · Chemical Biology & Drug Design · 715

Crystal structure of human acetylcholinesterase in complex with tacrine: Implications for drug discovery

2022 · K.V. Dileep, Kentaro Ihara, et al. · International Journal of Biological Macromolecules · 154

Targeting LIF/LIFR signaling in cancer

2021 · Suryavathi Viswanadhapalli, Kalarickal V. Dileep, et al. · Genes & Diseases · 117

PDF

EC359: A First-in-Class Small-Molecule Inhibitor for Targeting Oncogenic LIFR Signaling in Triple-Negative Breast Cancer

2019 · Suryavathi Viswanadhapalli, Yiliao Luo, et al. · Molecular Cancer Therapeutics · 74

Tumor Derived Extracellular Vesicles Drive T Cell Exhaustion in Tumor Microenvironment through Sphingosine Mediated Signaling and Impacting Immunotherapy Outcomes in Ovarian Cancer

2022 · Prachi Gupta, Ishaque Pulikkal Kadamberi, et al. · Advanced Science · 71

PDF

Cuminaldehyde as a Lipoxygenase Inhibitor: In Vitro and In Silico Validation

2014 · M. J. Tomy, K. V. Dileep, et al. · Applied Biochemistry and Biotechnology · 53

Molecular docking studies of curcumin analogs with phospholipase A2

2011 · K. V. Dileep, Ignatius Tintu, et al. · Interdisciplinary Sciences Computational Life Sciences · 51

Functionalised dihydroazo pyrimidine derivatives from Morita–Baylis–Hillman acetates: synthesis and studies against acetylcholinesterase as its inhibitors

2016 · Eeda Koti Reddy, Remya C., et al. · RSC Advances · 41

Design of potent inhibitors of acetylcholinesterase using morin as the starting compound

2012 · C. Remya, K. V. Dileep, et al. · Frontiers in Life Science · 40

PDF

Human glutaminyl cyclase: Structure, function, inhibitors and involvement in Alzheimer’s disease

2019 · Dileep K. Vijayan, Kam Y.J. Zhang · Pharmacological Research · 39

A comprehensive approach to ascertain the binding mode of curcumin with DNA

2016 · P. Haris, Varughese Mary, et al. · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · 39

Neuroprotective derivatives of tacrine that target NMDA receptor and acetyl cholinesterase – Design, synthesis and biological evaluation

2021 · Chandran Remya, K.V. Dileep, et al. · Computational and Structural Biotechnology Journal · 36

PDF

Flavanone glycosides as acetylcholinesterase inhibitors: computational and experimental evidence.

2015 · C Remya, K V Dileep, et al. · PubMed · 28

Inhibition of Beta-Lactamase by 1,4-Naphthalenedione from the Plant Holoptelea integrifolia

2009 · N. V. Vinod, R. Shijina, et al. · Applied Biochemistry and Biotechnology · 28

A loss-of-function variant in SUV39H2 identified in autism-spectrum disorder causes altered H3K9 trimethylation and dysregulation of protocadherin β-cluster genes in the developing brain

2021 · Shabeesh Balan, Yoshimi Iwayama, et al. · Molecular Psychiatry · 26

Amyloid Beta Hypothesis in Alzheimer's Disease: Major Culprits and Recent Therapeutic Strategies

2019 · Dileep Vijayan, Remya Chandra · Current Drug Targets · 26

TRAIL-based tumor sensitizing galactoxyloglucan, a novel entity for targeting apoptotic machinery

2014 · S.R. Aravind, Manu M. Joseph, et al. · The International Journal of Biochemistry & Cell Biology · 26

Derivatives Form Better Lipoxygenase Inhibitors than Piperine: In Vitro and In Silico Study

2014 · Muringayil J. Tomy, Chelankara S. Sharanya, et al. · Chemical Biology & Drug Design · 26

Gossypin as a Novel Selective Dual Inhibitor of v-raf Murine Sarcoma Viral Oncogene Homolog B1 and Cyclin-Dependent Kinase 4 for Melanoma

2013 · Shylesh Bhaskaran, Kalarikkal V. Dileep, et al. · Molecular Cancer Therapeutics · 26

In vitro inhibitory profile of NDGA against AChE and its in silico structural modifications based on ADME profile

2012 · Chandran Remya, Kalarickal Vijayan Dileep, et al. · Journal of Molecular Modeling · 23

Binding to PLA2 May Contribute to the Anti‐Inflammatory Activity of Catechol

2011 · Kalarickal V. Dileep, Ignatius Tintu, et al. · Chemical Biology & Drug Design · 23

An Isoquinoline Alkaloid, Berberine, Can Inhibit Fungal Alpha Amylase: Enzyme Kinetic and Molecular Modeling Studies

2012 · Ignatius Tintu, Kalarickal V Dileep, et al. · Chemical Biology & Drug Design · 22

PDF

Galactose‐Grafted 2D Nanosheets from the Self‐Assembly of Amphiphilic Janus Dendrimers for the Capture and Agglutination of Escherichia coli

2019 · Nithiyanandan Krishnan, Devanathan Perumal, et al. · Chemistry - A European Journal · 21

Piperidine-4-carboxamide as a new scaffold for designing secretory glutaminyl cyclase inhibitors

2020 · K.V. Dileep, Naoki Sakai, et al. · International Journal of Biological Macromolecules · 20

EC330, a small-molecule compound, is a potential novel inhibitor of LIF signaling

2020 · Xuetian Yue, Fangnan Wu, et al. · Journal of Molecular Cell Biology · 20

PDF

Works count: 101

Citation count: 2,059

H-index: 22

I10-index: 38